If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

A novel DIPN method enhances GA segmentation by integrating ConvLSTM, projection attention, adaptive pooling, and contrastive ...

The first surgical retina series of COPHy 2025 focuses on controversial approaches to common surgical questions. Clinicians will debate whether the inverted flap technique is the best surgical ...

BEIJING, April 2 (Reuters) - China's embassy in Australia rejected reports linking the transit of a Chinese research vessel south of Australia with the country's upcoming federal elections ...

With companies around the globe working to development new candidates for treating patients with retinal diseases ... is intended for the treatment of vision loss due to geographic atrophy (GA) ...

ABSTRACT: Hyperglycaemia is the hallmark of diabetes mellitus. It is a complicated chronic metabolic disease. These problems, which have long-term detrimental effects on key organs, including the eyes ...

These results suggest that the CP and/or LP are implicated in the development of AMD. Histological analyses were performed on retinal cross sections stained with hematoxylin and eosin (H&E). After ...

On March 17, the Shanghai Maritime Safety Administration released an announcement of traffic restrictions for a large vessel in the Yangtze River estuary on March 18. While the announcement did ...

A year since the Francis Scott Key Bridge collapsed after being struck by a large cargo ship, new studies are warning about the risk of vessel strikes over busy waterways in the U.S. After the Key ...